In the ever-evolving world of biotech, a groundbreaking technology is set to transform the landscape of mRNA manufacturing. Graduate student Nathan Stover from MIT is leading the charge with his innovative approach to in vitro transcription (IVT) through the implementation of a detailed mathematical model.
By joining forces with BioCurie, an emerging AI and bioinformatics company, Stover aims to revolutionize the process by shifting from traditional batch techniques to more efficient fed-batch processing. This shift not only promises to reduce manufacturing costs but also offers greater control over variables like pH, making it a game-changer for industries like biopharma. With a focus on creating a comprehensive mathematical model that accounts for all existing data, Stover’s work represents a significant leap forward in optimizing mRNA production. Discover how automation is paving the way for a new era of cost-effective and streamlined manufacturing in the biotech sector.
Read more from genengnews.com